We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$40.5B
AUM Growth
-$1.74B
Cap. Flow
-$1.03B
Cap. Flow %
-2.55%
Top 10 Hldgs %
7.42%
Holding
3,192
New
162
Increased
1,347
Reduced
1,471
Closed
153

Sector Composition

Rank Sector Weight
1 Healthcare 13.53%
2 Technology 11.68%
3 Financials 10.76%
4 Consumer Discretionary 10.34%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEF icon
1
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47B
$668M 1.65%
6,358,600
TLT icon
2
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$470M 1.16%
3,998,000
+1,558,900
+64% +$191M
AAPL icon
3
Apple
AAPL
$4.72T
$353M 0.87%
11,243,440
-1,809,572
-14% -$57.9M
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$282M 0.7%
1,370,395
+5,432
+0.4% +$1.14M
GILD icon
5
Gilead Sciences
GILD
$162B
$247M 0.61%
2,108,427
-130,227
-6% -$14.2M
DRII
6
DELISTED
DIAMOND RESORTS INTL, INC
DRII
$245M 0.61%
9,451,419
+108
+0% +$3.53K
AMGN icon
7
Amgen
AMGN
$201B
$202M 0.5%
1,312,664
+21,124
+2% +$3.38M
MSFT icon
8
Microsoft
MSFT
$2.83T
$183M 0.45%
4,150,764
-843,243
-17% -$38.5M
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.89T
$179M 0.44%
6,738,220
-779,844
-10% -$20.9M
CELG
10
DELISTED
Celgene Corp
CELG
$177M 0.44%
1,526,269
+133,824
+10% +$15.3M
META icon
11
Meta Platforms (Facebook)
META
$1.54T
$161M 0.4%
1,872,697
-5,490
-0.3% -$448K
BIIB icon
12
Biogen
BIIB
$29.6B
$157M 0.39%
389,787
+32,991
+9% +$13.2M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$68.3B
$137M 0.34%
269,122
+3,768
+1% +$1.84M
INTC icon
14
Intel
INTC
$504B
$129M 0.32%
4,242,665
-111,116
-3% -$3.59M
ABBV icon
15
AbbVie
ABBV
$454B
$128M 0.32%
1,904,067
+188,347
+11% +$12.3M
JNJ icon
16
Johnson & Johnson
JNJ
$624B
$125M 0.31%
1,280,878
-24,921
-2% -$2.5M
ZION icon
17
Zions Bancorporation
ZION
$10.1B
$124M 0.31%
3,897,447
-675,516
-15% -$19.9M
PFE icon
18
Pfizer
PFE
$143B
$122M 0.3%
3,843,837
+198,126
+5% +$6.46M
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$117M 0.29%
649,643
+28,834
+5% +$4.98M
QCOM icon
20
Qualcomm
QCOM
$180B
$117M 0.29%
1,867,522
-64,014
-3% -$4.37M
CSCO icon
21
Cisco
CSCO
$444B
$115M 0.28%
4,186,547
-554,411
-12% -$15.9M
LEN icon
22
Lennar Class A
LEN
$19.8B
$112M 0.28%
2,299,307
+6,439
+0.3% +$296K
DHI icon
23
D.R. Horton
DHI
$39.9B
$109M 0.27%
4,000,386
+249,905
+7% +$6.72M
AGN
24
DELISTED
Allergan plc
AGN
$105M 0.26%
345,198
+38,733
+13% +$11.6M
T icon
25
AT&T
T
$157B
$105M 0.26%
3,899,747
-342,741
-8% -$8.86M

Similar funds

Guggenheim Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Guggenheim Capital held 3,192 positions worth $40.5B, down 4.1% from $42.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Guggenheim Capital's Q2 2015 filing shows 162 new, 1,347 increased, 1,471 reduced and 153 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M. The largest sale was Covanta Holding Corporation, an estimated $71.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Guggenheim Capital's largest Q2 2015 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M.
  • Guggenheim Capital added most to Qorvo in Q2 2015, an estimated $45.3M increase.
  • Guggenheim Capital's biggest Q2 2015 reduction was Covanta Holding Corporation, cutting an estimated $71.6M.
  • Guggenheim Capital fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $66M.
  • Guggenheim Capital's ten largest holdings make up 7.4% of its $40.5B portfolio in Q2 2015.
  • Guggenheim Capital opened 162 new positions and closed 153 in Q2 2015.
  • Guggenheim Capital's portfolio value fell 4.1% quarter-over-quarter to $40.5B.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.